documents: FDA-2022-N-2174-0002

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-2174-0002 FDA FDA-2022-N-2174 Oncologic Drugs Advisory Committee; Cancellation Notice Meeting 2022-11-09T05:00:00Z 2022 11 2022-11-09T05:00:00Z   2022-11-09T13:40:59Z 2022-24470 0 0 090000648549d61a

Links from other tables